Diagnostic Imaging Pathways Logo

  • Pathways
  • Normal Anatomy
  • Medical Images
  • Radiation Module
  • Radiation Quiz
  • Menu
  • Search

Ectopic pregnancy (suspected)

Population Covered By The Guidance

This pathway provides guidance on the imaging of female patients presenting with suspected ectopic pregnancy

Lead Researcher: Dr Jack Liu

Experts & Contributors: Dr Virginia Saxton

Date reviewed: 2026

Date Published: June 2026

No available images

  • In stable patients, Transvaginal and Transabdomino-pelvic US is the mainstay of diagnosis. 
  • Ectopic pregnancy (EP) remains a leading cause of first-trimester maternal mortality due to haemorrhage.
  • Unstable patients should not be sent for formal imaging. Resuscitate and escalate urgently and perform bedside (point-of-care) US (RUQ + pelvis) to look for free fluid i.e. haemoperitoneum.
  • The presence of free fluid can support suspected rupture, but management is driven by clinical instability; absence of free fluid does not exclude ectopic rupture. 
  • The corpus luteum is the great mimicker of an ectopic pregnancy, and they frequently occur on the same side. 
  • The most common appearance of an ectopic pregnancy is usually an inhomogeneous mass or an echogenic ring with central lucency. To differentiate a tubal ectopic pregnancy from a haemorrhagic corpus luteum, the sonographer must use gentle transvaginal probe pressure. A corpus luteum will move with the ovary; an ectopic pregnancy mass will ‘slide’ independently of the ovary. 
  • Seeing an Intrauterine Pregnancy (IUP) does not mean the scan is over - 
    • An IUP almost always excludes an ectopic, but heterotopic remains a risk, especially with Assisted Reproductive Technology (ART)/ovulation induction and ongoing pain. 
  • Do not call an empty intrauterine fluid collection a definite IUP. A yolk sac or embryo makes it definite; otherwise describe it as a probable IUP if sac-like, or as fluid in the endometrial cavity if irregular/pointed/mobile. Intracavitary fluid lowers but does not exclude ectopic pregnancy risk.
  • A single high β-hCG level with an empty uterus is not an automatic diagnosis of ectopic pregnancy:
    • Historically, clinicians used a rigid ‘discriminatory zone’ (e.g. 1500 IU/L) where an IUP must be seen. Contemporary 2025/2026 guidelines strongly caution against this. A single β-hCG above a ‘zone’ with an empty uterus is not diagnostic. Use conservative thresholds, repeat assessment, and prioritise symptoms. Avoid methotrexate until diagnosis is secure. 
    • High β-hCG without an IUP should prompt an expedited repeat scan in 48-72 hours. 
  • ‘Pregnancy of Unknown Location’ (PUL) is a transient classification when there is no IUP, adnexal mass, or retained products of conception. It is not a disease. 
  • The anterior lower uterine segment should be carefully examined in any woman with a history of a Caesarean Section (C-section), to exclude a Caesarean Scar Pregnancy (CSP). 
  • Tubal ectopics that lie adjacent to the upper uterus need to be differentiated from an interstitial ectopic pregnancy that is partially exophytic (this is done by applying probe pressure to see if the ectopic moves independently to the uterus).

1. Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 191: Tubal Ectopic Pregnancy. Obstet Gynecol. 2018 Feb;131(2):e65–77. doi:10.1097/AOG.0000000000002464 PubMed PMID: 29232273.

2. Hendriks E, Rosenberg R, Prine L. Ectopic pregnancy: diagnosis and management. Am Fam Physician. 2020;101(10):599–606.

3. Moore C, Todd WM, O’Brien E, Lin H. Free fluid in Morison’s pouch on bedside ultrasound predicts need for operative intervention in suspected ectopic pregnancy. Acad Emerg Med Off J Soc Acad Emerg Med. 2007 Aug;14(8):755–8. doi:10.1197/j.aem.2007.04.010 PubMed PMID: 17554008.

4. Schreiber Courtney A., Sonalkar Sarita. Tubal Ectopic Pregnancy. N Engl J Med. 2025 Feb 19;392(8):798–805. doi:10.1056/NEJMcp2402787

5. Nadim B, Infante F, Lu C, Sathasivam N, Condous G. Morphological ultrasound types known as “blob” and “bagel” signs should be reclassified from suggesting probable to indicating definite tubal ectopic pregnancy. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2018 Apr;51(4):543–9. doi:10.1002/uog.17435 PubMed PMID: 28195383.

6. Atri M. Ectopic pregnancy versus corpus luteum cyst revisited: best Doppler predictors. J Ultrasound Med Off J Am Inst Ultrasound Med. 2003 Nov;22(11):1181–4. doi:10.7863/jum.2003.22.11.1181 PubMed PMID: 14620888.

7. Lee IT, Rubin ES, Wu J, Koelper N, Barnhart KT. The incidence and importance of the pseudogestational sac revisited. Am J Obstet Gynecol. 2022 Apr;226(4):537.e1-537.e7. doi:10.1016/j.ajog.2021.10.033

8. Rodgers SK, Horrow MM, Doubilet PM, Frates MC, Kennedy A, Andreotti R, et al. A Lexicon for First-Trimester US: Society of Radiologists in Ultrasound Consensus Conference Recommendations. Am J Obstet Gynecol. 2025 Jan;232(1):1–16. doi:10.1016/j.ajog.2024.07.038 PubMed PMID: 39198135.

9. Pereira PP, Cabar FR, Gomez ÚT, Francisco RPV. Pregnancy of unknown location. Clinics. 2019;74:e1111. doi:10.6061/clinics/2019/e1111 PubMed PMID: 31618321; PubMed Central PMCID: PMC6784610.

10. Park KE, Latack KR, Vestal NL, Ingles SA, Paulson RJ, Awadalla MS. Association of HCG Level with Ultrasound Visualization of the Gestational Sac in Early Viable Pregnancies. Reprod Sci. 2023 Dec;30(12):3623–8. doi:10.1007/s43032-023-01308-7 PubMed PMID: 37563479; PubMed Central PMCID: PMC10692031.

11. Webster K Hilary|Fishburn,Sarah|Kumar,Geeta. Ectopic pregnancy and miscarriage: diagnosis and initial management: summary of updated NICE guidance. Bmj-Br Med J. 2019;367:l6283–l6283.

12. Chadee A, Rezai S, Kirby C, Chadwick E, Gottimukkala S, Hamaoui A, et al. Spontaneous Heterotopic Pregnancy: Dual Case Report and Review of Literature. Case Rep Obstet Gynecol. 2016;2016:2145937. doi:10.1155/2016/2145937 PubMed PMID: 27413561; PubMed Central PMCID: PMC4930808.

13. Maleki A, Khalid N, Rajesh Patel C, El-Mahdi E. The rising incidence of heterotopic pregnancy: Current perspectives and associations with in-vitro fertilization. Eur J Obstet Gynecol Reprod Biol. 2021 Nov 1;266:138–44. doi:10.1016/j.ejogrb.2021.09.031

14. Society for Maternal-Fetal Medicine (SMFM), Miller R, Gyamfi-Bannerman C, Publications Committee. Electronic address: pubs smfm.org. Society for Maternal-Fetal Medicine Consult Series #63: Cesarean scar ectopic pregnancy. Am J Obstet Gynecol. 2022 Sep;227(3):B9–20. doi:10.1016/j.ajog.2022.06.024 PubMed PMID: 35850938.

15. Kaelin Agten A, Cali G, Monteagudo A, Oviedo J, Ramos J, Timor-Tritsch I. The clinical outcome of cesarean scar pregnancies implanted “on the scar” versus “in the niche.” Am J Obstet Gynecol. 2017 May;216(5):510.e1-510.e6. doi:10.1016/j.ajog.2017.01.019 PubMed PMID: 28115056.

16. Ash A, Smith A, Maxwell D. Caesarean scar pregnancy. BJOG Int J Obstet Gynaecol. 2007 Mar;114(3):253–63. doi:10.1111/j.1471-0528.2006.01237.x PubMed PMID: 17313383.

17. Stabile G, Mangino FP, Romano F, Zinicola G, Ricci G. Ectopic Cervical Pregnancy: Treatment Route. Medicina (Mex). 2020;56(6):293. doi:10.3390/medicina56060293

18. Yonghan W, Meishu P, Jingchu T, Lihua L, Jinjin L, Shujing W. Ultrasound-Based Diagnosis of Interstitial Ectopic Pregnancy: Role of Morphological Features. J Clin Ultrasound. 2026;54(2):517–23. doi:10.1002/jcu.70067

Pathway User Guide

Yellow Boxes Denotes extra information. Some contain single or multiple white sub-boxes, click a white box to reveal detailed information in a pop-up.

White Boxes: Denotes standard pathway steps. (If inside a yellow box, they open a specific pop-up).

Zoom & Pan Controls: Use + / − or the slider to zoom. Reset returns to default. Tick Panning to drag the diagram when zoomed.

Blue “View Full Screen” Button: Opens the whole diagram in a large, full-screen pop-up window. Use Close to exit.

The relative radiation level (RRL) of each imaging investigation is displayed in the pop up box.

SYMBOL RRL EFFECTIVE DOSE RANGE
No radiation None 0
Minimal radiation Minimal < 1 millisieverts
Low radiation Low 1-5 mSv
Medium radiation Medium 5-10 mSv
High radiation High >10 mSv

Disclaimer

Status Of Recommendations Each pathway is designed to assist clinicians in situations when faced with a large array of possible diagnostic tests and examinations. However, it is recognised that diagnostic practice may differ from a particular pathway depending on local availability of equipment and expertise, as well as the experience of individual clinicians. Therefore each pathway is neither a rigid set of rules, nor a substitute for clinical assessment, and individual patient circumstances should always be considered.

Report an Issue

Spotted an error or outdated info? Click to tell us.

Patient clinically unstable Ectopic pregnancy (EP) suspected 1 Resuscitate + urgent O&G/surgical escalation2 Bedside focused Ultrasound (assess for haemoperitoneum/free fluid) Patient clinically stable Pregnancy of unknown location (PUL) Check adnexa with TVUS(heterotopic risk) If adnexal mass seen, refer O&G urgently Likely developing IUP but ectopic not excluded Pregnancy unlikely to continue Urine pregnancy test in 14 days(or trend β-HCG to negative) Treat as ruptured →Urgent surgical pathway Urgent specialist pathway (same-day consultant level O&G +/- tertiary referral) TVUS in 7-14 days; consider earlier scan if β-hCG > 1500 IU/l If negative: no further action (symptom dependent)If positive: return for review within 24 hours Between 50% fall and 63% rise Higher risk of ectopic/persistent PUL Immediate O&G referral/review Definite ectopic pregnancy- Extrauterine gestational sac with yolk sac/embryo/cardiac activity Rise >63% Fall >50% Yes Yes No No Routine antenatal care Take two serum β-hCG measurement approx. 48 hours apart Moderate/large complex free fluid (+/- RUQ fluid)ORInstability/peritonismORHeavy bleeding Non-tubal ectopic suspected(Caesarian Scar pregnancy/cervical/interstitial/ovarian/abdominal)

Transvaginal US (TVUS) + Transabdominal US (TAUS)

In stable patients, Transvaginal and transabdominal-pelvic US is the mainstay of diagnosis

  • TVUS is the primary imaging test for suspected ectopic pregnancy (EP) in stable patients
  • Complementary TAUS is performed to provide a pelvic overview (uterine position and high adnexa), to help assess larger adnexal masses, and to evaluate for large-volume free fluid; images of the right upper quadrant (Morison’s pouch) are included when symptoms raise concern for significant haemoperitoneum
  • A complete examination documents: the uterus (sagittal/transverse), endometrium, cervix, both ovaries and adnexa (confirm whether any mass is extra-ovarian), and the pouch of Douglas/cul-de-sac, +/- significant free fluid or clot
  • Minimum reporting items include: 
    • Category (definite/probable Intrauterine Pregnancy (IUP); definite/probable EP; PUL*) 
    • Site (tubal vs non-tubal suspected) 
    • Adnexal mass size (max. diameter, mm) and relationship to ovary
    • Contents (sac/yolk sac/embryo; cardiac activity) 
    • Free fluid amount/character (simple vs complex)

*PUL= Pregnancy of unknown location (a positive pregnancy test with no definite/probable IUP or EP on TVUS)

Probable ectopic pregnancy (EP)

Classic appearances of an ectopic pregnancy include the “Blob” and “Bagel” signs, which have high specificity

  • A probable tubal ectopic is suspected when TVUS shows an extra-ovarian adnexal abnormality typical of EP but without diagnostic contents (yolk sac/embryo)
  • Classic appearances are:
  • Blob sign - inhomogeneous extra-ovarian adnexal mass
  • Bagel/tubal ring sign - echogenic ring with central lucency (tubal ring)
  • These signs have very high specificity and positive predictive value (>95%) for tubal EP in published series/meta-analysis; the recommendation is for expedited clinical review and safety-netting regardless of β-hCG trend. Doppler may show peripheral flow, but it is not diagnostic by itself. Mass size, relationship to the ovary (movement independent of the ovary), and any free fluid (complex or anechoic) should be documented.
  • Corpus Luteum Pitfall: The ectopic pregnancy is usually located on the same side as the corpus luteum. Gentle transducer pressure should be applied to slide the mass away from the ovary to differentiate an ectopic mass from an exophytic corpus luteum cyst.

Intrauterine pregnancy (IUP) seen

Do not mistake fluid in the endometrial cavity for a definite Intrauterine Pregnancy (IUP)

  • The earliest gestational sac is usually a round or oval fluid collection with a hyperechoic trophoblastic rim. A yolk sac within that collection makes the diagnosis of a definite IUP. Without a yolk sac or embryo, an empty round/oval sac-like collection is better regarded as a probable gestational sac/probable IUP, not a definite IUP. The intradecidual sign and double decidual sac sign as well as the sac lying eccentric to the cavity centre increase confidence when present, but are not required and are not sensitive. 
  • Avoid the terms “pseudosac” and “pseudogestational sac”. Suspicious non-sac uterine fluid should be described as “intracavitary fluid” or “fluid in the endometrial cavity,” especially when it has pointed/non-curved margins or variable internal echoes and/or is mobile with probe pressure or position change. 
  • Intracavitary uterine fluid does not exclude ectopic pregnancy, but it makes ectopic much less likely. In a study conducted by Lee et al., only 8/162 ectopics (4.9%) had an intrauterine fluid collection, compared with 363/789 intrauterine pregnancies (46.0%). Among women with an intrauterine fluid collection, the ectopic rate was 2.2% and the IUP rate was 97.8% . 
  • Sac size does not reliably distinguish an early gestational sac from intracavitary fluid associated with ectopic pregnancy. Lee et al. found substantial overlap and no useful discriminatory threshold; several ectopics with intrauterine fluid also had other suspicious findings, especially an adnexal mass . 
  • Practical message: assess the whole scan, not just the uterine cavity - adnexal mass, free fluid, symptoms, and interval change still matter.

Take two serum β-hCG measurements ~48 hrs apart

Serial β-hCG measurements are useful to follow-up ‘Pregnancy of unknown Location’ (PUL)

  • PUL means a positive pregnancy test with no definite/probable Intrauterine Pregnancy (IUP) or ectopic pregnancy (EP) on TVUS
  • Serial β-hCG measurements are used to guide follow-up but β-hCG should not be used to determine location . Two β-hCG values are obtained as near as possible to 48 hrs apart (not earlier) 
  • Interpretation of change of β-hCG over 48 hrs :
    • Rise >63% → likely developing IUP (ectopic not excluded) - 
      • Management recommended: TVUS 7–14 days, consider earlier if β-hCG ≥1500 IU/L
    • Fall >50% → pregnancy unlikely to continue -
      • Management recommended: urine pregnancy test 14 days after second β-hCG (return within 24h if positive)
    • Between 50% fall and 63% rise → higher risk ectopic/persistent PUL - 
      • Management recommended: clinical review within 24 hrs, further tests only after senior review. Provide written return advice to the patient, with emphasis that symptoms trump β-hCG.

IVF/high heterotopic risk/disproportionate symptoms?

A definite Intrauterine Pregnancy (IUP) makes ectopic pregnancy (EP) unlikely except in high-risk settings such as IVF

  • A definite IUP usually makes an ectopic unlikely, but does not completely exclude heterotopic pregnancy, especially in higher-risk settings e.g. IVF/Assisted Reproductive Technology (ART) or when symptoms are disproportionate (severe unilateral pain, significant adnexal tenderness, or unexplained free fluid)
  • In these situations, the adnexa should be carefully assessed even when an IUP is confirmed and any extra-ovarian adnexal mass, free fluid characteristics, and any site suspicious for non-tubal implantation isreported. 
  • If a suspicious adnexal mass is present, urgent clinical review is recommended rather than reassurance based on the intrauterine finding alone.

Moderate/large complex free fluid (± RUQ) OR clinical peritonism/instability?

Moderate or large volume of complex free fluid requires urgent O&G review

  • For suspected/confirmed ectopic pregnancy (EP), moderate or large complex free fluid should be treated as haemoperitoneum until proven otherwise, especially if echogenic/clotted predominantly in one adnexa, or free fluid present in the right upper quadrant
  • Imaging should not delay escalation
  • It is important to note that some non-tubal ectopics (e.g. cervical/Caesarian Scar Pregnancy) may bleed predominantly vaginally/uterine, so ‘no free fluid’ does not exclude danger - clinical instability, peritonism, syncope, or heavy bleeding overrides laboratory trends
  • If features of rupture are present, recommend immediate senior O&G/surgical review and communicate directly (phone) per escalation policy.

Non-tubal ectopic suspected?

Non-tubal ectopic pregnancy includes Caesarean Section scar implantation, Cervical implantation and Interstitial implantation

  • Non-tubal ectopics require clear reporting and same-day specialist pathway (often consultant-level O&G ± tertiary centre referral)
  • Non-tubal ectopic pregnancy (EP) should be considered when features suggest:
    • Caesarean Section scar implantation: Sac in anterior lower uterine segment scar region; thin/absent myometrium between sac and bladder; often hypervascular
    • Cervical implantation: Sac in the cervix; caution miscarriage-in-progress is a mimic, it will be mobile with US probe pressure
    • Interstitial implantation: Eccentric high cornual sac; myometrial mantle <5 mm, lies external to the endometrial cavity. If partially exophytic to the myometrium, moves with the uterus on probe pressure . 
  • Reporting should include: the exact site, the relationship to the cervix/scar/uterine cavity, a myometrial mantle where relevant, vascularity, and any features of haemorrhage.

Unstable patients

Unstable patients require resuscitation and urgent escalation as well as point-of-care US

Unstable patients should be resuscitated, escalated urgently for O&G/surgical opinion and point-of-care US performed of the abdomen (including the RUQ) and pelvis to identify haemoperitoneum/free fluid.

  • Acute Abdomen
  • Breast
  • Cancer Staging
  • Cardiovascular
  • Ear, Nose & Throat
  • Endocrine
  • Gastrointestinal
  • Kidney and Urinary Tract
  • Liver and Biliary
  • Musculoskeletal Non-Trauma
  • Neurological
  • Obstetric & Gynaecological
  • Paediatric
  • Pancreas
  • Respiratory
  • Trauma
    • Trauma - Musculoskeletal
    • Trauma - Head
    • Trauma - Visceral
    • Trauma - Paediatric
  • Obstetric & Gynaecological

    • Obstetric & Gynaecological
      • Adnexal masses (incidental)
      • Amenorrhoea (secondary)
      • Bleeding (abnormal pre-menopausal)
      • Bleeding (Antepartum)
      • Bleeding (First Trimester)
      • Bleeding (Postmenopausal)
      • Cervical cancer (staging)
      • Ectopic pregnancy (suspected)
      • Endometriosis (suspected)
      • Fetal Wellbeing (Assessment, Third Trimester)
      • First trimester screening
      • Hydronephrosis (Antenatal and Paediatric)
      • Intrauterine Growth Restriction (Suspected)
      • Ovarian Cancer (Staging)
      • Pelvic inflammatory disease (suspected)
      • Tubo-ovarian torsion (suspected)
    • Respiratory
      • Pulmonary Embolism (Pregnancy, Suspected)

    Diagnostic Imaging Pathways

    The DIP pathways are a step-by-step guides to help clinicians choose the most appropriate imaging for each clinical scenario 

    “Trusted by clinicians worldwide since 2007, Diagnostic Imaging Pathways provides clear, evidence-based imaging guidelines. Our pathways support better decision-making and help improve healthcare outcomes—especially in emerging nations. 

    DIP functions and thrives wholeheartedly under the pillars of diversity, inclusivity and respect for all."

    • Pathways
    • Normal Anatomy
    • Medical Images
    • Radiation Module
    • Radiation Quiz
    • Information for Consumers
    • Governance
    • About Imaging
    • Production
    • Search
    • Login
    • Get in Touch
    © Diagnostic Imaging Pathways (DIP) 2025
    Code of Conduct    Terms and Conditions of Use
    General Site Navigation

    Information For Consumers

    • General Information About Diagnostic Imaging
      • Colorectal (Bowel) Cancer Screening
      • Colorectal (Bowel) Cancer Screening (Australia)
      • Consent to Procedure or Treatment
      • Radiation Risks of X-rays and Scans
    • Imaging Pathways
      • Ankle Injury (Suspected)
      • Bowel Cancer (Staging)
      • Deep Venous Thrombosis ( Leg, Suspected)
      • Deep Venous Thrombosis (Arm, Suspected)
      • Headache (Constant or Repeated)
      • Hip Fracture (Suspected)
      • Hypertension
      • Low Back Pain (Acute)
      • Lung Cancer (Staging)
      • Neck Pain (Non-Traumatic)
      • Renal Colic
      • Respiratory Illness (Acute)
      • Scaphoid Fracture (Suspected)
      • Shoulder (Pain or Instability)
      • Sinusitis (Acute)
      • Sinusitis (Chronic)
      • Stress Fracture (Suspected)
    • Imaging Procedures
      • Angiography (Angiogram)
      • Arthrogram
      • Bone Scan
      • Computed Tomography (CT)
      • Computed Tomography (CT) Angiography
      • Inferior Vena Cava (IVC) Filters
      • Intravenous Pyelogram (IVP)
      • Magnetic Resonance Angiography (MRA)
      • Magnetic Resonance Imaging (MRI)
      • Myelogram
      • Orthopantomogram (OPG)
      • Percutaneous Transthoracic Fine Needle Aspiration (FNA) or Biopsy
      • Positron Emission Tomography (PET)
      • Renal Artery Angioplasty and Stent
      • Renal Scan
      • Ultrasound
      • Ultrasound (Doppler)
      • Ultrasound (Endoscopic Rectal)
      • Venography (Venogram)
      • X-ray (Chest)
      • X-ray (Plain Radiograph)

    Governance

    • History
      • 1990s to 2012
      • 2012 to 2016
      • 2016 to 11 April 2022
      • From 12 April 2022
      • Introduction
      • List of acronyms used on this site
    • Organisation
      • 2003 - 2012
      • 2013 - 2016
      • 2017 - 11 April 2022
      • Post 12 April 2022
    • Personnel
      • Clinical Advisors
      • Contractors
      • Contributors
      • Editor
      • Editorial Panel - Post 2022
      • Editorial Panel - Pre 2022
      • Executive Sponsor
      • Information Technologist
      • Manager
      • Other Personnel
      • Project Officers
      • Quality Coordinator
      • Research Registrar
      • Responsibilites
      • Steering Committee
      • Steering Committee
    • Responsibilities, Achievements
      • Accreditation and Endorsement
      • Clinical Advisors
      • Editor
      • Editorial Panel
      • Executive Sponsor
      • Information Technologist
      • Manager
      • Other Personnel
      • Pathway Creation, Review and Revision
      • Quality Coordinator
      • Research Registrar
      • Steering Committee

    About Imaging

    • About Imaging
      • Bleeding Risk and Assessment
      • General Principles in Requesting and Providing Imaging Investigations
      • Imaging During Pregnancy and Lactation
      • Ionising Radiation in Diagnostic Imaging
      • Ionising Radiation in Paediatric Imaging
    • Common Procedures
      • Computed Tomography
      • Gastrointestinal Contrast Examinations
      • High Resolution Computed Tomography
      • Magnetic Resonance Imaging
      • Nuclear Medicine
      • Positron Emission Tomography
      • Ultrasound
    • Contrast Agents
      • Gadolinium Contrast for MRI scans
      • Iodinated Contrast for CT scans
      • Ultrasound Contrast Media

    Production

    • Editorial Independence
      • Disclosure of Conflict of Interest
      • Funding Policy & Sources
      • Management of Conflict of Interest
    • Processes for Creating and Managing Content
      • Creation of a New Pathway
      • Creation of New Information for Consumers
      • Review and Revision of a Pathway
      • Review and Revision of Information for Consumers
    • Production
      • Initial Engagement with Consumers
      • Principles for Creating and Managing Content